LUMOS PHARMA, INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lumos Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
  • Lumos Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.64M, a 14.5% increase year-over-year.
  • Lumos Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36.3M, a 2.49% decline year-over-year.
  • Lumos Pharma, Inc. annual Operating Income (Loss) for 2023 was -$36.6M, a 14.3% decline from 2022.
  • Lumos Pharma, Inc. annual Operating Income (Loss) for 2022 was -$32M, a 2.21% decline from 2021.
  • Lumos Pharma, Inc. annual Operating Income (Loss) for 2021 was -$31.3M, a 19.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$36.3M -$7.64M +$1.29M +14.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$37.6M -$7.82M +$1.82M +18.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$39.4M -$10.9M -$2.83M -35.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$36.6M -$10M -$1.17M -13.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$35.4M -$8.93M -$1.38M -18.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$34.1M -$9.64M -$1.72M -21.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$32.3M -$8.04M -$304K -3.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$32M -$8.84M -$2.27M -34.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$29.8M -$7.55M -$53K -0.71% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$29.7M -$7.92M +$740K +8.54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$30.5M -$7.73M +$886K +10.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$31.3M -$6.57M +$485K +6.88% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$31.8M -$7.5M -$340K -4.75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$31.5M -$8.66M -$1.79M -26% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$29.7M -$8.62M -$3.4M -65.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$26.3M -$7.05M +$1.64M +18.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$27.9M -$7.16M -$4.46M -165% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$23.5M -$6.88M -$4.28M -165% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$19.2M -$5.22M -$3.08M -144% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$16.1M -$8.69M +$2.26M +20.6% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-03
Q3 2019 -$18.4M -$2.7M +$12.3M +82.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$30.7M -$2.6M +$15.2M +85.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$45.9M -$2.14M +$16.6M +88.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-02
Q4 2018 -$62.4M -$10.9M +$3.11M +22.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$65.5M -$15M +$5.87M +28.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 -$71.4M -$17.7M -$1.02M -6.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 -$70.4M -$18.7M +$2.49M +11.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 -$72.9M -$14.1M -$81K -0.58% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$72.8M -$20.9M -$4.22M -25.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-05
Q2 2017 -$68.6M -$16.7M +$17.8M +51.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-05
Q1 2017 -$86.4M -$21.2M +$4.2M +16.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-05
Q4 2016 -$90.6M -$14M +$855K +5.77% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 -$91.4M -$16.7M -$1M -6.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-05
Q2 2016 -$90.4M -$34.5M -$18.6M -117% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-05
Q1 2016 -$71.8M -$25.4M -$38.2M -298% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-05
Q4 2015 -$33.6M -$14.8M -$164M -110% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 $130M -$15.7M -$2.66M -20.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 $133M -$15.9M -$6.82M -74.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 $140M $12.8M +$22.2M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 $118M $149M +$157M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$39.4M -$13M -$4.91M -60.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$34.5M -$9.13M -$2.06M -29.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$32.4M -$9.3M -$1.26M -15.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$31.1M -$7.91M -$1.62M -25.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$29.5M -$8.12M -$2.27M -38.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$27.3M -$7.07M -$768K -12.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$26.5M -$8.04M -$3.23M -67% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$23.3M -$6.29M -$489K -8.43% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-12
Q3 2012 -$22.8M -$5.85M -$1.88M -47.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-12
Q2 2012 -$20.9M -$6.3M -$1.91M -43.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-12
Q1 2012 -$19M -$4.82M -$925K -23.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-12
Q4 2011 -$18.1M -$5.8M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$3.97M +$1.14M +22.3% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$4.39M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$3.89M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$5.11M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.